RxDoctor Payments Data

Pooja Virmani, MD

Dermatology · New Providence, NJNPI 1881038339

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 113 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 19.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $742 and has fallen 96.9% since, to $23 in 2025. That places this record below the midpoint for dermatology clinicians in NJ, where the typical reported total is $1,986.

$1,862in general payments, 2019–2025

Across 113 payments — averaging $16.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$367
  • Novartis$306
  • LEO Pharma Inc.$213
  • Sun Pharmaceutical Industries Inc.$187
  • Amgen$157
  • Sanofi$103
  • plus $529 from 14 others

What the payments were for

  • Food & beverage$1,862100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,862 in reported general payments places this provider in the 45th percentile of 394 dermatology providers in New Jersey.

See all dermatology providers in New Jersey →

Medicare billing

Part B allowed, 2024
$208,006
Medicare patients
625
Services billed
2,693

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate101$5,318
Ketoconazole126$2,070
Fluorouracil26$1,735
Triamcinolone Acetonide131$1,036
Clindamycin Phosphate17$631
Mupirocin63$477
Ciclopirox15$456
Fluticasone Propionate24$436
Hydrocortisone49$271
Doxycycline Monohydrate19$234

Paid to pharmacies, not to this prescriber.

Other dermatology in New Providence

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →